Stocks · Health care · Services-Medical Laboratories

Labcorp

LH Clue Score34
United States Fiscal year ends December CIK 0000920148 Results filed 28 Oct 2026

What the insiders did Net selling

By person

36 insiders · 221 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
David P King
Director
—
$63.14M (15) scheduled
−$63.14M
344,155
0.4244%
$121.73M
+77.8%
Glenn A Eisenberg
Executive Vice President
—
$34.20M (27) scheduled
−$34.20M
37,920
0.0468%
$13.41M
+358.6%
Adam H Schechter
President & CEO
—
$14.69M (10) scheduled
−$14.69M
102,565
0.1265%
$36.28M
+2,192%
der Vaart Sandra D van
EVP, Corporate Affairs
—
$8.53M (33) scheduled
−$8.53M
6,239
0.0077%
$2.21M
+368.6%
Kerrii B Anderson
Director
—
$7.56M (19) scheduled
−$7.56M
6,563
0.0081%
$2.32M
−62.5%
Mark S Schroeder
EVP, Pres Diagnostics & COO
—
$7.42M (22) scheduled
−$7.42M
12,677
0.0156%
$4.48M
+1,951%
Jean-Luc Belingard
Director
—
$6.41M (4) scheduled
−$6.41M
17,781
0.0219%
$6.29M
−41.8%
Lance Berberian
EVP, Special Advisor, Strategy
—
$5.28M (6)
−$5.28M
18,652
0.0230%
$6.60M
+1,436%
F Samuel Eberts III
Chief Legal Officer, Secretary
—
$4.89M (1) scheduled
−$4.89M
28,823
0.0355%
$10.19M
+59.5%
Paul R Kirchgraber
CEO, Covance Drug Development
—
$3.95M (4) scheduled
−$3.95M
12,946
0.0160%
$4.58M
+193.8%
Peter J Wilkinson
SVP, Chief Accounting Officer
—
$3.73M (15) scheduled
−$3.73M
1,770
0.0022%
$626.13K
+1,270%
Edward T Dodson
Principal Accounting Officer
—
$2.84M (3) scheduled
−$2.84M
13,663
0.0168%
$4.83M
+311.3%
Lisa J Uthgenannt
Chief Human Resources Officer
—
$2.69M (4)
−$2.69M
4,660
0.0057%
$1.65M
+23.3%
Amy B. Summy
EVP, Chief Marketing Officer
—
$2.27M (7) scheduled
−$2.27M
6,956
0.0086%
$2.46M
—
Richelle P Parham
Director
—
$2.17M (2)
−$2.17M
2,288
0.0028%
$809.27K
—
R Sanders Williams
Director
—
$1.47M (11)
−$1.47M
8,120
0.0100%
$2.87M
+50.0%
Robert E Mittelstaedt Jr
Director
—
$1.37M (6) scheduled
−$1.37M
15,515
0.0191%
$5.49M
+36.7%
Dwight Gary Gilliland
Director
—
$1.30M (11)
−$1.30M
6,656
0.0082%
$2.35M
+128.6%
Peter M Neupert
Director
$922.82K (3)
—
+$922.82K
13,784
0.0170%
$4.88M
—
Brian J Caveney
EVP, Pres of BLS, CMO & CSO
$20.42K (2)
$923.46K (2)
−$903.03K
36,492
0.0450%
$12.91M
+3,767%
Jonathan C Meltzer
EVP, COO
—
$298.76K (4) scheduled
−$298.76K
3,620
0.0045%
$1.28M
+43.8%
M. Huff Gary
CEO, LabCorp Diagnostics
—
$293.82K (1)
−$293.82K
1,850
0.0023%
$654.21K
+359.4%
Kathryn W Kyle
EVP, Chief Legal Officer
—
$227.41K (2) scheduled
−$227.41K
3,904
0.0048%
$1.38M
+27.9%
Bryan T Vaughn
EVP and President, Diagnostics
—
$175.20K (2) scheduled
−$175.20K
6,845
0.0084%
$2.42M
+30.5%
Jonathan P. DiVincenzo
EVP, Pres, Central Labs & Intl
—
$107.75K (1)
−$107.75K
5,461
0.0067%
$1.93M
+65.0%
Judith C Seltz
EVP, CHRO
$99.36K (2)
—
+$99.36K
4,182
0.0052%
$1.48M
+1,075%
John D Ratliff
CEO, Covance Drug Development
—
—
—
16,941
0.0209%
$5.99M
—
Garheng Kong
Director
—
—
—
13,739
0.0169%
$4.86M
+308.4%
Jeffrey A. Davis
Director
—
—
—
5,460
0.0067%
$1.93M
—
Akinbolade Oyegunwa
EVP, CIO & CTO
—
—
—
5,316
0.0066%
$1.88M
+99.4%
Anita Z Graham
EVP, CHRO
—
—
—
5,185
0.0064%
$1.83M
+17,183%
Megan D. Bailey
EVP, Pres, Central Labs & Intl
—
—
—
4,851
0.0060%
$1.72M
+3,876%
Kathryn E Wengel
Director
—
—
—
4,133
0.0051%
$1.46M
—
Kirsten Marie Kliphouse
Director
—
—
—
3,160
0.0039%
$1.12M
—
Paul Rothman
Director
—
—
—
2,571
0.0032%
$909.36K
+19,677%
Julia Aijun Wang
Chief Financial Officer, EVP
—
—
—
1,817
0.0022%
$642.76K
+29,027%